NDC properties for "eribulin mesylate 1 MG per 2 ML Injection" (RxCUI 1045456)
About this data
The tables show NDC propoerties for eribulin mesylate 1 MG per 2 ML Injection with the RxCUI 1045456
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for eribulin mesylate 1 MG per 2 ML Injection (RxCUI 1045456)
| ANDA | ANDA214850 |
|---|---|
| ANDA | ANDA217250 |
| ANDA | ANDA218047 |
| ANDA | ANDA218281 |
| ANDA | ANDA218743 |
| MMSL_CODE | BD26641 |
| MMSL_CODE | CD26641 |
| RxCUI | 1045456 |
| SPL_SET_ID | 4a64918a-f674-4843-b544-ab815fdd1b8f |
| SPL_SET_ID | 62690292-b1de-46f1-b6e8-012a725f8c63 |
| SPL_SET_ID | 64bf3c30-f06a-3615-ca5e-eb4154d371d0 |
| SPL_SET_ID | 7752b084-cdc7-6eac-e294-e45db82c372a |
| SPL_SET_ID | 8a81f3e9-ac52-4f98-bf62-da7974d012b3 |
| SPL_SET_ID | aa69e7a5-fa82-4984-b9d2-653c772b80e3 |
| SPL_SET_ID | f57835e2-4c53-4e93-b54b-7d7a5000ae3d |
| VUID | 4030274 |
| Prescribable Synonym | eriBULin mesylate 1 MG in 2 ML Injection |
| RXNAV_STR | 2 ML eriBULin mesylate 0.5 MG/ML Injection |
| RxNorm Name | 2 ML eribulin mesylate 0.5 MG/ML Injection |
| RxNorm Synonym | eribulin mesylate 1 MG per 2 ML Injection |
| Tallman Synonym | 2 ML eriBULin mesylate 0.5 MG/ML Injection |
| Tallman Synonym | eriBULin mesylate 1 MG per 2 ML Injection |
| Related queries | Interactions (for RxCUI 1045456) |
NDC Properties
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |
NDC Item 00143916701
| NDC 9 | 0143-9167 |
|---|---|
| NDC 10 | 0143-9167-01 |
| NDC Item | 00143916701 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218281 |
| FDA SPL set id | 867126 |
| Labeler | HIKMA PHARMACEUTICALS USA INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9167 |
NDC Item 10019008001
| NDC 9 | 10019-080 |
|---|---|
| NDC 10 | 10019-080-01 |
| NDC Item | 10019008001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA217250 |
| FDA SPL set id | 816217 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 10019-080 |
NDC Item 60505628900
| NDC 9 | 60505-6289 |
|---|---|
| NDC 10 | 60505-6289-0 |
| NDC Item | 60505628900 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 785024 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6289 |
NDC Item 60505643500
| NDC 9 | 60505-6435 |
|---|---|
| NDC 10 | 60505-6435-0 |
| NDC Item | 60505643500 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 865998 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-19 |
| Marketing status | active |
| Related queries | Properties for NDC 9 60505-6435 |
NDC Item 68083059201
| NDC 9 | 68083-592 |
|---|---|
| NDC 10 | 68083-592-01 |
| NDC Item | 68083059201 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218047 |
| FDA SPL set id | 780904 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-592 |
NDC Item 71731417101
| NDC 9 | 71731-4171 |
|---|---|
| NDC 10 | 71731-4171-1 |
| NDC Item | 71731417101 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA218743 |
| FDA SPL set id | 865376 |
| Labeler | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-04 |
| Marketing status | active |
| Related queries | Properties for NDC 9 71731-4171 |
NDC Item 81298389001
| NDC 9 | 81298-3890 |
|---|---|
| NDC 10 | 81298-3890-1 |
| NDC Item | 81298389001 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA214850 |
| FDA SPL set id | 800808 |
| Labeler | Long Grove Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-07-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 81298-3890 |